Aurora Cannabis Inc (ACB)

[N.C.LUCKY(7)]

Update from Aurora IR: Medreleaf Exeter Greenhouse sale... Thank you for reaching out to the Investor Relations team at Aurora. We apologize for the delay in the getting back to you; while I understand your frustration we do ask for your patience as we have worked through a high volume of inquires received over the holidays which has resulted in slightly longer response time.



The Exeter facility was inherited by Aurora through the acquisition of MedReleaf in 2018.

We have taken time over the past year to evaluate the potential to utilize the greenhouse for R&D or extraction based activities. We have concluded that this non-operational greenhouse would require retrofit and significant capital investment in order to meet Aurora’s production standards. As has always been the case, our core business model to operate as a low-cost, high-quality producer remains in place, driven by our commitment to purpose-built, state-of-the-art facilities.

Aurora has taken decisive steps to rationalize capital expenditures and align our cultivation footprint to current demand, including selling the Exeter facility. We expect that our production capacity, including the anticipated completion of 6 grow rooms at Aurora Sun, to be sufficient for near term demand.


Best,



Investor Relations ¦ Aurora Cannabis
Phone: [phone]
Email: [e-mail]
Stock: TSX ¦ NYSE:ACB